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ABSTRACT 
Optimized formulations were subjected to various in vivo studies like anti-inflammatory activity, Nickel induced dermatitis, irritation study and 
Acute and repeated dose dermal toxicity studies. Clobetasol propionate (CP) has anti-inflammatory, immunomodulatory, and antiproliferative 
activity. The aim of the present work was to test the hypothesis that the addition CP in nanoemulsions would result in enhancement CP delivery 
and leading to better antipsoriatic activity. Nanoemulsions were prepared by aqueous phase titration method, using Tea Tree oil, Tween 20, 
Transcutol P, and distilled water as the oil phase, surfactant, co-surfactant and aqueous phase, respectively.We developed a topical O/W 
nanoemulsion in which drug is incorporated in disperse phase of oil and evaluated its efficacy against different types of in vivostudies. It was also 
found that the significantly increased their anti-inflammatory activity. It was reported that CP-loaded nanoemulsion significantly increased 
NTPDase (Nucleoside triphosphate diphosphohydrolases) activity in lymphocytes. This membrane protein is responsible for the hydrolysis of 
extracellular ATP (Adenosine triphosphate) which is responsible for cell proliferation, differentiation and inflammatory processes. In 
vivoirritation studies did not show any irritation in spite of having high amount of surfactant. Group treated with CP loaded nanoemulsion gel 
showed no evident toxicity even on repeated exposure. On the basis of above in vivo study we conclude that developed nanoemulsion is safe for 
human. 
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Topical corticosteroids are one of the most commonlyused 
and mostbeneficial for dermatologic disorders. The 
clinicalvalue of the tropical corticosteroids in the 
treatmentof psoriasis and other skin disease is related with 
their vasoconstrictive, anti-inflammatory, immune 
suppressive, and antiproliferative properties1.Regardless of 
its clinicalusefulness, the application of topical glucocorticoid 
is limited due to their adverse effects, such as skin atrophy, 
steroid acne, hypo pigmentation, allergic contact dermatitis 
and their poor absorption through skin 2.The recent 
advancementon the corticosteroids are to developed the 
strategiesto enhance the benefit-risk ratio of 
glucocorticosteroids specially increase their absorption and 
should be free from the any histopathological change in the 
natural structure of skin3.In last two decades, nano sized 
based formulation has emerged as an excellent tool in the 
drug delivery system especially the nanoemulsions for 
delivery of the poorly water soluble drug to the dermis of the 
skin with an intention to decreasing the side effects via 
decreasein dose 4, 5.In such cases, the particle size is decrease 
to its sub-micron level upto 10-200 nm to increase the 
absorption and therapeutic application of the drug in the 
target tissue. It may permitreproducible and long-term 
release of the drug at the site of action6, 7. Clobetasol 
propionate (CP) is a potent, highly hydrophobic 
corticosteroid used for the treatment of skin ailments such 
as atopic dermatitis and psoriasis 8.Henceoil/water (O/W) 
nanoemulsion is one of the best approaches in which drug 
present in oil phase. But, Innanoemulsion there is high 
amount of surfactant and cosurfactant are used which has 
irritation potential so, researchermustassessthe irritation 
potential before application 9, 10.The reported article of 
Senyigit showed that the incorporation of CP into 
lecithin/chitosan nanoparticles induced an accumulation of 
CP especially in the epidermis without any significant 
permeation across pig ear skin11. The psoriasis may occurs 
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because of the delayed hypersensitivity reaction, mediated 
by T lymphocyte to an antigen protein or a hapten linked to a 
protein also, the extracellular ATP (Adenosine triphosphate), 
which is able to regulate the cell - cell interactions and play 
important role in the processes of cell activation, 
differentiation, development, proliferation, and death, as 
well as effector lymphocyte response 12, 13. NTPDase (ecto-
nucleoside triphosphate diphosphohydrolase; CD39) is an 
integral membrane protein that metabolizes 
extracellular.Taking all these considerations into account, 
vivo protocol was developed based on the induction of 
contact dermatitis in rats usingthe in a dispersion of nickel 
sulfate in solid Vaseline at 5%, carrageenan induce 
inflammation,their irritation study, acute and repeated dose 
dermal toxicity studies14. Inflammation is the one of the most 
significant clinical symptom related with psoriasis and other 
skin diseases. So, it was also investigated in these studies. 
High amount of surfactant and co-surfactant was used in 
nanoemulsion, which has irritation potential so, irritation 
study was also performed. In such type of skin disease needs 
long terms treatment so acute and repeated dose dermal 
toxicity studies were also performed. 
MATERIALS AND METHODS 
 Materials 
CP was obtained as a gift sample from Ranbaxy Research 
Laboratory (Gurgaon, India).  Tea Tree Oil (TTO) was a gift 
sample from Natural Aroma Products Pvt. Ltd. New Delhi, 
INDIA. PEG 400, Tween 80, Tween 20 and ethanol was 
purchased from Merck (Merck, India). Caprylocaproyl 
macrogol-6 glycerides (Labrasol), diethyleneglycol 
monoethyl ether (Transcutol P) and Plurol Oleique were 
obtained as a kind gift sample from Gattefosse (Mumbai, 
India). All other chemicals were of analytical grade. 
Preparation of optimized nanoemulsion 
On the basis of solubility studies Tea Tree oil (TTO), Tween 
20 and Transcutol P were selected as oil, surfactant and co-
surfactant respectively. Different combination of surfactant 
and cosurfactant were prepared commonly known as Smix. 
To find out the nanoemulsion region pseudo ternary phase 
diagrams were constructed for each Smix ratio. Finally 
Smix(1:1) was selected for the preparation of nanoemulsion. 
A number of nanoemulsion formulations were prepared 
based on the different ratio of oil: Smix (1:1): water and 
evaluated for their physical stability studies. Considering the 
irritation potential of surfactants, Smix ratio containing 
minimum percentage of surfactant was selected for the 
preparation nanoemulsion Optimized nanoemulsion was 
prepared by dissolving 0.05% (w/v) of CP in 15% (v/v) TTO 
then 35% (v/v) mixture of Tween-20 and ethyl alcohol (1:1 
v/v) were added slowly in oil phase. Then remaining amount 
of distilled water was added slowly to get the final 
preparation of 100% (v/v) [data unpublished]. 
Dermatitis induction by 5% nickel sulfate 
Contact dermatitis was induced by 5% nickel sulfate in solid 
Vaseline similar to the procedure adopted by Brum et al. 
Animals were divided into five sets (n = 8). After 
tricotomization, all groups received sensitization with nickel 
sulfate in the abdomen, except the first group which received 
only solid Vaseline and continued under the same 
environmental and feeding conditions as the other groups, 
this being the control group (C). The induction of dermatitis 
was done 6 days after sensitization by nickel sulfate in solid 
Vaseline (5 applications with an interval of 72 hours) in each 
ear after tricotomization. The first group which received only 
solid Vaseline was euthanized 72 h after the last application 
of the sensitization agent. The second group was induced to 
allergic contact dermatitis, which was not managed, and the 
rats were euthanized 72 h after the last application of nickel 
sulfate, being the positive control (D). The third group 
received the topical administration in each ear of the placebo 
nanoemulsion the fourth received topical administration in 
each ear of the CP loaded nanoemulsion and fifth group 
received marketed preparation. Dose of application for CP 
loaded nanoemulsion and marketed formulation was equal 
to 1 microgram of CP. Group 4 & 5 were treated daily with 
0.5 gram of the drug loaded nanoemulsion and marketed 
formulation for 5 days on days 1, 3, and 5. All formulations 
were applied uniformly throughout the ear tissue with 
massage in order to obtain a better drug penetration. After 
the completion of each treatment, the animals were 
euthanized and the blood was collected by cardiac puncture 
to determine the NTPDase activity15,16. For NTPDase activity 
of lymphocytes, mononuclear leukocytes were isolated from 
rat blood collected with EDTA and separated using Ficoll-
Hypaque density gradients as described by Memon et al. 
After the isolation of mononuclear cells, NTPDase activity 
was determined by colorimetric assay in compliance with 
Leal et al.  All samples were run in duplicate or triplicate, and 
specific activity is reported as nmol Pi released/ min/mg 
protein. Protein was measured by the Coomassie Blue 
method using bovine serum albumin as the standard as 
described by Bradford et al17.  
In vivo anti-inflammatory study 
The protocol to carry out in vivo anti-inflammatory efficacy 
studies was approved by the Institutional Animal Ethics 
Committee (IAEC) of Jaipur National University, Jaipur 
Rajasthan. The committee’s guidelines were followed for the 
studies. The anti-inflammatory activity of optimized 
formulations (Nanoemulsion gel A2) was evaluated using the 
carrageenan induced hind paw edema method developed by 
Winter et al. The edema of paw was measured with the help 
of digital plethysmomter.Young Wister rats, weighing 150-
250 g, were randomly divided into four groups, each 
containing six rats. One group out of four was subjected to 
optimized placebo nanoemulsion gel, optimized 
formulations (Nanoemulsion gel A2), marketed formulation 
and control. The digital plethysmometer 7140 is a volume 
meter; designed for accurate measurement of the rat paw 
swelling. It consists of water filled Perspex cell into which 
the rat paw is dipped. A transducer of original design, which 
records small difference in water level caused by volume 
displacement; operates on a graphic LCD read out which 
shows the exact volume of the paw (control or treated). The 
measuring cell consists of two vertical inter-connected 
Perspex tube; the larger one is used to measure the 
displacement of water. The water level in the smaller tube, 
which contains the transducer, follows the change in level of 
water in the larger tube. Therefore proportional changes in 
water level occur when something is dipped in.It 
conductance is linearly proportional to the water level but is 
also affected by water conductivity, which in turn depends 
on its ions contents and temperature. A sophisticated 
electronic circuit monitored by the compensator electrodes, 
corrects the level of electrons. Thus the reading generates 
signal proportional to the water-level only and hence to the 
volume of the dipped object.The rats were given free access 
to water and food. The rats were kept under observation for 
24 h. The backside of rats was shaved 12 h before starting 
the experiment18. The optimized placebo nanoemulsion gel, 
optimized formulations (Nanoemulsion gel A2) and 
marketed formulation were applied on the shaved backs of 
all animals of group no. 2, 3 and 4 respectively. Right hind 
paw edema was induced in all three groups of animals by sub 
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planter injection of 0.1 ml of a 1% w/v homogeneous 
suspension of carrageenan in distilled water. In animals of 
group no. 2, 3 and 4 carrageenan was injected half an hour 
later the application of formulations. The swelling of the 
injected paw was measured immediately (0 h) and at 0.5, 1, 
2, 3, 4, 5, 6, 8, 12 and 24 h after injection using a digital 
plethysmometer19. The amount of paw swelling was 
determined from time to time and expressed as percent 
edema relative to the initial hind paw volume. The mean 
values of percentages were determined for each time 
interval. Percentage inhibition of edema produced by each 
group was calculated against the respective control group 
using the following formula: 
              
                                        
                 
 
 Where,  
Mean edema =  
Mean of final paw volume – Mean of initial paw volume 
            
                                        
                  
     
In vivo skin irritation test 
All the materials used for preparation of nanoemulsion fall 
under generally regarded as safe (GRAS) category. 
Concentration of all materials is very critical issue for this 
formulation.  Large amount of surfactants is usually irritant 
to the skin. Therefore skin irritation test was performed to 
confirm concentration of materials used for nanoemulsion 
preparation is safe. Therefore skin irritation test was 
performed to confirm the safety of optimized nanoemulsion 
gel of CP. Van-Abbe et al. mentioned that a value between 0 
and 9 indicates that the applied formulation is generally non 
tirritant to human skin. Skin irritation test was performed on 
optimized formulation, Placebo nanoemulsion and marketed 
cream on wistar rats weighing 180–200 g. Wistar rats were 
divided into 3 groups: placebo nanoemulsion gel, optimized 
nanoemulsion gel of CP and Marketed preparation were 
applied to each group, one group contain 6 rats. The animals 
were kept under standard laboratory conditions, 
temperature at 25 ± 1°C and relative humidity (55 ± 5%). 
The animals were housed in polypropylene cages, six per 
cage, with free access to standard laboratory diet and water 
as mention above. A single dose of 10 mg of placebo 
nanoemulsion gel, optimized nanoemulsion gel of CP and 
Marketed preparation were applied to the left ear of the rat 
and the right ear as a control. The development of erythema 
was monitored for 14 days using the reported method20, 21.  
In vivoAcute and repeated dose dermal toxicity studies 
Acute and repeated dose dermal toxicity studies were 
performed in accordance with 2002 and OECD, 1981. Briefly, 
albino Wistar rats weighing between 200 and 300 g were 
randomized and assigned to the treatment and control 
groups (each group contained six rats). Test formulations 
were applied uniformly over depilated skin (approximately 
10% of the body surface area). A 100 times higher dose of 
human exposure was selected for acute dermal toxicity study 
while usable dose was selected for repeated dose dermal 
toxicity study. For acute dermal toxicity, exposure period 
comprised of 24 h and the observation period was of 14 
days22. For repeated dose dermal toxicity, the animals were 
treated for 6 h per day on a 6-day per week basis, for a total 
period of 28 days. Animals were observed and individual 
records were maintained throughout the study period for 
any changes in vital physiological functions of respiratory, 
circulatory, autonomic and central nervous system and 
pharmacological signs such as tremors, convulsions, 
salivation, diarrhea, lethargy, sleep somatomotor activity 
and behavior pattern. At the conclusion of study period, 
blood samples were collected for hematology and 
biochemistry determinations. All the animals in each 
experimental group were humanely sacrificed using ether 
anesthesia. The animals were dissected and major organs 
namely liver, kidney, heart, lung and spleen were collected 
and weighed carefully in order to calculate organ to body 
weight ratios. The tissue samples were preserved in formalin 
(10% buffered neutral) and processed for histopathology by 
cutting sections of 5 μm thickness and staining with 
hematoxylin and eosin23.  
RESULT AND DISCUSSION 
Contact dermatitis 
The in vivo NTPDase activity of lymphocytes after each 
treatment is shown in (Fig.1).A significant increase in 
NTPDase activity was observed in lymphocytes of the group 
treated with CP-loaded nanoemulsion, in relation to ATP and 
ADP (Adenosine Diphosphate) (Fig. 1A and 1B, respectively), 
compared to all other groups (p < 0.05). The ADP and the 
ATP hydrolysis values for the group treated with CP loaded 
nanoemulsion and the control groups were not statistically 
different. The higher NTPDase activity may be associated 
with the high levels of extracellular ATP resulting from the 
inflammatory process, which occurs in cases of allergic 
contact dermatitis. During the dermatitis, these high levels of 
ATP would have an affinity for drug loaded nanoemulsion. 
Data were analyzed statistically by one-way ANOVA followed 
by the Tukey–Kramer test (1A) and Kruskal–Wallis Test 
(1B), p < 0.05. 
P2X7 purinergic receptors, leading to a Th1 pattern of 
immune response with the production of inflammatory 
cytokines. The NTPDase would act by decreasing the levels 
of ATP, which in low concentration would bind to the P2Y 
receptors, reversing the pattern of immune response to Th2 
with the release of anti-inflammatory cytokines. Thus, it is 
possible that the increased hydrolysis of adenine nucleotides 
also leads to an increase in the extracellular adenosine 
concentration, which has immunosuppressive and anti-
inflammatory effects. Adenosine plays a central and direct 
role in the regulation of inflammatory responses and in 
limiting inflammatory tissue destruction. In this context, the 
higher NTPDase activity in the treatment with the CP-loaded 
nanoemulsion, at intervals of 48 h, could be related to the 
higher anti-inflammatory effect in comparison with placebo 
nanoemulsion and marketed preparation. Therefore, the best 
result observed for the CP loaded nanoemulsion at 0.05%, 
even after a longer interval of time, may be related to the 
slower CP release as found and its accumulation in the hair 
follicles in the form of nanosize (data unpublished). This 
result demonstrates that the nanoemulsion formulation, 
which did not appear to stimulate an inflammatory or 
immune response using the contact dermatitis model. 
In vivo anti-inflammatory study 
The anti-inflammatory effects of placebo nanoemulsion gel, 
optimized drug loaded nanoemulsion gel and marketed 
conventional gel with the control. The anti-inflammatory activity 
of optimized nanoemulsion was evaluated using the carrageenan-
induced hind paw edema method using digital Plethysmometer. 
The rat's left footpad became edematous soon after injection of 
carrageenan and reached its peak at 12 h (39.31 %). Mean 
percent edema and % inhibition of inflammation of all the three 
groups were calculated and mentioned in (Table 1). Inhibition of 
edema was found to be highest in the groups in which optimized 
nanoemulsion was applied. The optimized nanoemulsion 
inhibited edema (P< 0.05) 84.51% up to 12 h. In case of placebo 
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nanoemulsion inhibited edema (P< 0.05) 33.9% up to 12 h. This 
action may be due to Tea Tree oil present in nanoemulsion, as this 
oil shows anti- inflammatory activity based on the anti-
inflammatory studies, it can be concluded that CP optimized 
nanoemulsion shows maximum inhibition of edema than the 
placebo24. Infect marketed preparation has greater activity than 






Figure 1: ATP (A) and ADP (B) hydrolysis in lymphocytes obtained from the control group (C), contact dermatitis group 
(D), groups with dermatitis treatedwith Placebo nanoemulsion, drug loaded nanoemulsion and marketed gel 
preparation. 
Table 1: Anti-inflammatory effects of Placebo nanoemulsion gel and Drug loaded nanoemulsion gel and in carrageenan-
induced rat paw edema 










6 180.0±12.2 1 28.72±2.33  
2 41.20±4.24  
3 74.45±4.32  
6 58.14±3.05  
12 39.31±3.57  
II Placebo nanoemulsion 6 200.0±15.5 1 26.9±2.81 6.27 
2 36.31±2.01 11.86 
3 62.84±4.16 15.59 
6 45.11±1.88 22.37 
12 25.99±1.25 33.9 
III Drug loaded nanoemulsion 6 190±9.5 1 25.43±4.16 11.39 
2 32.16±1.01 21.94 
3 41.34±1.97 44.47 
6 14.97±1.05 74.23 
12 6.09±1.11 84.51 
IV Marketed preparation 6 195±10.31 1 26.4±3.12 8.013 
2 35.91±4.16 12.83 
3 62.87±3.37 15.55 
6 41.59±3.05 28.42 
12 21.22±3.55 46.03 
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In vivo skin irritation test 
The mean values of skin irritation score for placebo 
nanoemulsion gel,  optimized drug loaded nanoemulsion gel 
and marketed conventional gel were found to be 1.50±0.54, 
1.66±1.03and 1.00±0.89respectively (Table 2). From these 
results which were based on 14 days test it can be concluded 
that optimized nanoemulsion was safe to be used as topical 
drug delivery system. It clearly indicated that nanoemulsion 
has more skin irritation potential due to high amount of 
surfactant in comparison to placebo nanoemulsion because 
drug itself may has irritation potential. Overall all the 
formulation have low irritation score hence it is safe for 
human use. 
 
Table 2: Skin irritation score of the Placebo nanoemulsion and Drug loaded nanoemulsion. 




























1 2 1 2 1 2 1.50±0.54 
2 Drug  loaded 
Nanoemulsion gel 
2 0 2 3 2 1 1.66±1.03 
3 Marketed gel 2 1 0 1 0 2 1.00±0.89 
 
In vivoAcute and repeated dose dermal toxicity studies 
Dermal toxicity studies provided detailed insight on any 
possible health hazards likely to arise from repeated 
exposures over a limited period of time. Acute as well as 
repeated application of test formulations did not reveal any 
abnormal changes in cage side observations. There was no 
mortality in any of the study groups. All study groups 
showed normal weight and exhibited no toxic effects during 
the study period. Histopathology of all major organs such as 
liver, kidney, spleen, heart and lung did not reveal any 
distinct pathological alterations (Fig.2). 
However, examination of application site skin area 
demonstrated dermal changes such as mild keratosis on 
repeated application of CP gel. Repeated exposure of CP gel 
showed slight collagenous mass infiltration in the subdermal 
layer, but no inflammatory reaction. No such reaction was 




Figure 2: Histopathology of all major organs such as liver, kidney, spleen, heart and lung 
 
CONCLUSION 
On the basis of above in vivo study we conclude that 
developed nanoemulsion is safe for human use because it 
has good anti-inflammatory action and did not show any 
irritation to the skin. Although nanoemulsion contain high 
amount of surfactant in comparison to market gel. 
Surprisingly, group treated with CP loaded nanoemulsion 
gel showed no evident toxicity even on repeated exposure, 
demonstrating significantly improved safety. 
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